Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Cryosite Limited ( (AU:CTE) ).
Cryosite Limited announced a change in the director’s interest, with Mark Kerr acquiring an additional 231,453 fully paid ordinary shares, bringing his total to 7,231,453 shares. This change, conducted through both off-market and on-market trades, reflects a strategic move in the company’s governance structure, potentially impacting its market positioning and stakeholder interests.
More about Cryosite Limited
Cryosite Limited operates in the biotechnology sector, focusing on the storage and management of biological materials. The company provides services related to the preservation of cord blood and tissue, catering primarily to healthcare providers and research institutions.
YTD Price Performance: -11.18%
Average Trading Volume: 8,226
Technical Sentiment Signal: Sell
Current Market Cap: A$36.85M
Learn more about CTE stock on TipRanks’ Stock Analysis page.